Sharon Bio-Medicine Ltd - SHARON BIO-MED. Share Price

Sector: Pharmaceuticals | ISIN: INE028B01029
₹ 3.30 (-4.35%) icon28 Mar, 2019, 3:24:26 PM
Open
₹ 3.30
Prev. Close
₹ 3.45
Turnover(lac)
₹ 0.00
Day's High
₹ 3.30
Day's Low
₹ 3.30
52 Wk High
₹ 0.00
52 Wk Low
₹ 0.00
Book Value
₹ -14.82
Face Value
₹ 2.00
Mkt. Cap (Cr.)
₹ 39.25
P/E
2.01
EPS
1.60
Div. Yield
0.00

Sharon Bio-Medicine Ltd KEY RATIOS

Sharon Bio-Medicine Ltd Corporate Actions

10 Apr , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

No Record Found


Sharon Bio-Medicine Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Sharon Bio-Medicine Ltd SHAREHOLDING SNAPSHOT
19 May , 2024 | 01:34 AM

PROMOTER - TOTAL0.00%

Indian: 0.00%

Foreign: 0%

NON-PROMOTER - TOTAL 100.00%

Institutions: 0.19%

Non-Institutions: 99.81%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Sharon Bio-Medicine Ltd FINANCIALS

View Profit & Loss Graph

Sharon Bio-Medicine Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Sharon Bio-Medicine Ltd

  • Savita Gowda
  • Chairman & Managing Director
  • Lalit Misra
  • Whole-time Director
  • Nivedita Patil
  • Director
  • Harish Palecanda
  • Director

Summary

Incorporated in 1989,Sharon Bio-Medicine Ltd is engaged in the pharmaceuticals/chemicals segment.The company had developed a number of products in active pharmaceutical ingredient (API), intermediates and formulations. During the fiscal year ended June 30, 2010, it had set up an active pharmaceutical ingredients plant in Taloja near Navi Mumbai.The company had installed capacity of 150,000 liters of reactors capacity of API and intermediates, and 2.5 billion tablets per shift per annum and one billion capsules per shift per annum. Its products include Trimetazidine Di Hydrochloride, Ketoconzole, Pentaprazole, Amlodipine Besylate, Atomoxetine Hcl, Carisoprodl, Closantel Base, Glimepiride, Ketoconazole, Nifedipibe, Racecadotril, Toldimfos, Telmisartan, Tamsulosin, Itraconazole, Mesalazine, Lansoprazole and Doxorubicin Inj.In January 2010,the Company started its toxicology laboratory and research and development unit at Taloja, Navi... Read More


Reports by Sharon Bio-Medicine Ltd


Reports by Sharon Bio-Medicine Ltd

Company FAQ

No Record Found